Pharmacists Push for Expanded Role as Implementation of Bill 67 Lags
The Quebec Association of Pharmacy Owners (AQPP) is voicing concerns over the delayed implementation of the expanded powers granted to pharmacists under Bill 67, passed in 2024.
Bill 67 is designed to enhance certain healthcare practices, particularly for pharmacists. The legislation enables pharmacists to administer medications for therapeutic purposes and substitute medications in a broader range of situations.
However, progress is hindered by the need for a new comprehensive agreement to govern these new professional responsibilities, given that the previous agreement expired on March 31, 2025. The AQPP has been in negotiations with the government to establish a remuneration framework for the additional activities authorized by Bill 67.
AQPP President Benoit Morin expressed frustration with the slow pace of negotiations, emphasizing the urgency to leverage the network of 1,900 pharmacies to invest in clinical services and provide better healthcare to the public. The AQPP is advocating for fair compensation that recognizes the increased workload resulting from the expanded pharmacist roles.
The objective of Bill 67 is to alleviate pressure on primary care by allowing pharmacists to take on more responsibilities, thereby easing the burden on physicians. Morin highlighted the potential for pharmacists to have greater autonomy in treating common conditions like urinary tract infections and uncomplicated cellulitis.
As the AQPP continues to push for progress in negotiations, the focus remains on ensuring that the expanded roles for pharmacists align with public health needs and are implemented effectively.
Keyphrase: Pharmacist Role Expansion
